KYLEE DREISBACH: Open Payments
NPI 1699494823 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,617 in 91 payments from 17 companies in 2025. Trend: 2023 $3,126 · 2024 $3,684 · 2025 $1,617
Food & beverage: $1,539Education: $78
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 26 | $311 |
| Janssen Biotech, Inc. | 12 | $290 |
| ABBVIE INC. | 12 | $211 |
| UCB, Inc. | 9 | $161 |
| PFIZER INC. | 7 | $132 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Mallinckrodt Hospital Products Inc. | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $57 |
| Aurinia Pharma U.S., Inc. | 3 | $50 |
Products named: TREMFYA, Bimzelx, RINVOQ, KRYSTEXXA, ENBREL, ACTHAR, RYBREVANT, XELJANZ.
Industry payments across KY — which companies pay providers there.
